Evaluation of the Performance and Safety of a Medical Device Developed to Improve the Reading of Dyslexic Patients (DysLight)
Evaluation of the Performance and Safety of a Scintillating Lamp Developed to Improve the Reading of Dyslexic Patients
Sponsor: SATT Ouest Valorisation
This NA trial investigates Dyslexia and is currently completed. SATT Ouest Valorisation leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
May 2021 — Jul 2024 [monthly]
Completed NA
Status: Recruiting → Completed
-
Jan 2021 — May 2021 [monthly]
Recruiting NA
-
Nov 2020 — Jan 2021 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Feb 2020 — Nov 2020 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Dec 2019 — Feb 2020 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- SATT Ouest Valorisation
- Slb Pharma
For direct contact, visit the study record on ClinicalTrials.gov .